MAGH:NASDAQMagnitude International Ltd Analysis
Data as of 2026-05-19 - not real-time
$6.76
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Magnitude International Ltd (MAGH) is trading at a flat $6.76 with a 20‑day and 50‑day SMA exactly at the current price, indicating no clear directional bias. The RSI of 92 signals extreme overbought conditions, while the MACD histogram is negative and the signal line is bearish, suggesting short‑term downside pressure. Fundamentally, the company reports negative gross (10.8%) and operating margins, a trailing EPS of zero, and a massive price‑to‑book ratio near 476, highlighting severe valuation disconnect. Cash flow is deeply negative, with operating cash flow of –$4.6 M and free cash flow of –$6.8 M, and a debt‑to‑equity of 45%, underscoring liquidity strain.
Material news includes an announced IPO pricing and an ongoing securities‑fraud investigation by Wolf Haldenstein Adler Freeman & Herz LLP, which adds legal uncertainty to an already fragile financial picture. Combined with a beta of –0.86 (inverse market correlation) and a historic max drawdown of nearly 75%, the stock exhibits high volatility and limited upside potential at current levels.
Material news includes an announced IPO pricing and an ongoing securities‑fraud investigation by Wolf Haldenstein Adler Freeman & Herz LLP, which adds legal uncertainty to an already fragile financial picture. Combined with a beta of –0.86 (inverse market correlation) and a historic max drawdown of nearly 75%, the stock exhibits high volatility and limited upside potential at current levels.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 9/10
Key Factors
- Extreme overbought RSI and bearish MACD
- Negative margins and cash flow
- Ongoing securities‑fraud investigation
Medium Term
1–3 yearsCautious
Model confidence: 8/10
Key Factors
- Persistently high price‑to‑book ratio
- Elevated debt levels relative to equity
- Uncertain legal environment
Long Term
> 3 yearsCautious
Model confidence: 7/10
Key Factors
- Structural profitability challenges
- Potential for continued legal and regulatory setbacks
- Limited upside given current valuation metrics
Key Metrics & Analysis
Financial Health
Revenue Growth-4.50%
Profit Margin-11.07%
ROE-44.15%
ROA-8.35%
Debt/Equity45.12
P/B Ratio476.3
Op. Cash Flow$-4640541
Free Cash Flow$-6800590
Industry P/E29.5
Technical Analysis
TrendNeutral
RSI92.2
Support$6.76
Resistance$6.76
MA 20$6.76
MA 50$6.76
MA 200$4.79
MACDBearish
VolumeStable
Fear & Greed Index89.32
Valuation
GradeOvervalued
TypeValue
Risk Assessment
Beta-0.86
0Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.